Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | NOS3 | P29474 | 1/20 | 0.45 |
| ▸ | NOS1 | P29475 | 1/20 | 0.45 |
| ▸ | NOS2 | P35228 | 1/20 | 0.45 |
| ▸ | TTR | P02766 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | CCNC | P24863 | 3/20 | 0.43 |
| ▸ | CDK8 | P49336 | 3/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | GABRP | O00591 | 1/20 | 0.43 |
| ▸ | GABRD | O14764 | 1/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.43 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.43 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5371971 | 0.89 | DPP4 (0.47) | DPP4ESR1TTRCA12CA1 | |
| SCHEMBL5371975 | 0.89 | DPP4 (0.47) | DPP4ESR1TTRCA12CA1 | |
| SCHEMBL29550737 | 0.82 | DPP4 (0.48) | DPP4ESR1TTRCA12CA1 | |
| SCHEMBL20439711 | 0.82 | DPP4 (0.48) | DPP4ESR1TTRCA12CA1 | |
| SCHEMBL2672353 | 0.80 | GABRP (0.53) | ESR1NOS3NOS1NOS2CA1 | |
| SCHEMBL2672351 | 0.80 | GABRP (0.53) | ESR1NOS3NOS1NOS2CA1 | |
| Hydrochloric Acid SCHEMBL2272813 | 0.79 | GABRP (0.51) | ESR1NOS3NOS1NOS2CA1 | |
| SCHEMBL14508733 | 0.79 | ESR1 (0.50) | DPP4ESR1TTRCA12CA1 | |
| SCHEMBL20523335 | 0.78 | HSD17B10 (0.45) | DPP4ESR1TTRCA12CA1 | |
| SCHEMBL20523334 | 0.78 | HSD17B10 (0.45) | DPP4ESR1TTRCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110190283-A1 | Fab I Inhibitors | DEBIOPHARM INTERNATIONAL SA (CH) | 2011-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190283-A1 | Fab I Inhibitors | SERPINB1, TFPI, TFPI2 | DPP4 3234/4885ESR1 3931/4885NOS3 3753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.